Application 213226

Type
ANDA
Sponsor
MSN LABORATORIES PRIVATE LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PREGABALINPREGABALINTABLET, EXTENDED RELEASE;ORAL82.5MGNoNo
002PREGABALINPREGABALINTABLET, EXTENDED RELEASE;ORAL165MGNoNo
003PREGABALINPREGABALINTABLET, EXTENDED RELEASE;ORAL330MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
55700-955PREGABALINPREGABALINQuality Care Products, LLCANDACurrent
55700-956PREGABALINPREGABALINQuality Care Products, LLCANDACurrent
69539-127PREGABALINPREGABALINMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-127PREGABALINPREGABALINMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-128PREGABALINPREGABALINMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-128PREGABALINPREGABALINMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-129PREGABALINPREGABALINMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-129PREGABALINPREGABALINMSN LABORATORIES PRIVATE LIMITEDANDACurrent
72205-077PREGABALINPREGABALINNovadoz Pharmaceuticals LLCANDACurrent
72205-078PREGABALINPREGABALINNovadoz Pharmaceuticals LLCANDACurrent
72205-079PREGABALINPREGABALINNovadoz Pharmaceuticals LLCANDACurrent